Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Texas Instruments
TXN
|
+$1.94B |
| 2 |
Marvell Technology
MRVL
|
+$1.94B |
| 3 |
Adobe
ADBE
|
+$1.84B |
| 4 |
Celanese
CE
|
+$1.15B |
| 5 |
Capital One
COF
|
+$875M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$2.3B |
| 2 |
Broadcom
AVGO
|
+$1.7B |
| 3 |
D.R. Horton
DHI
|
+$1.4B |
| 4 |
GE Aerospace
GE
|
+$1.29B |
| 5 |
Micron Technology
MU
|
+$1.22B |
Sector Composition
| 1 | Technology | 24.18% |
| 2 | Healthcare | 15.85% |
| 3 | Consumer Discretionary | 13.35% |
| 4 | Industrials | 11.99% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
DT Midstream
DTM
$10.6B
| $78.1M | 0.02% |
1,574,719
-439,324
| -22% | -$21.8M |
|
302
Extra Space Storage
EXR
$30.4B
| $77.9M | 0.02% |
523,193
+7
| +0% | +$1.04K |
|
303
First Advantage
FA
$2.74B
| $76.9M | 0.02% |
4,988,399
| – | – |
|
304
SentinelOne
S
$6.08B
| $76.3M | 0.02% |
5,056,283
+2,399,658
| +90% | +$36.2M |
|
305
SiriusPoint
SPNT
$2.12B
| $75.4M | 0.02% |
8,350,000
-650,000
| -7% | -$5.87M |
|
306
Silicon Laboratories
SLAB
$4.39B
| $73.2M | 0.02% |
464,000
| – | – |
|
307
Fiserv
FI
$72B
| $67.7M | 0.02% |
536,700
| – | – |
|
308
Unity
U
$19.1B
| $66.6M | 0.02% |
1,532,815
| – | – |
|
309
US Bancorp
USB
$75.1B
| $66.3M | 0.02% |
2,007,401
+1,082
| +0.1% | +$35.7K |
|
310
Nutrien
NTR
$27.5B
| $66.1M | 0.02% |
1,119,111
+510
| +0% | +$30.1K |
|
311
Kenvue
KVUE
$34.8B
| $66.1M | 0.02% |
+2,500,800
| New | +$66.1M |
|
312
On Holding
ONON
$13.8B
| $65.4M | 0.02% |
1,980,610
| – | – |
|
313
Sarepta Therapeutics
SRPT
$1.91B
| $63.8M | 0.02% |
557,383
+291,442
| +110% | +$33.4M |
|
|
CHX
314
DELISTED
ChampionX
CHX
| $62.9M | 0.02% |
2,025,494
+173,732
| +9% | +$5.39M |
|
315
GSK
GSK
$81B
| $62.5M | 0.02% |
1,752,350
+1,032
| +0.1% | +$36.8K |
|
316
Levi Strauss
LEVI
$8.88B
| $62M | 0.02% |
4,295,300
| – | – |
|
317
Emerson Electric
EMR
$73.1B
| $61.9M | 0.02% |
684,425
+416
| +0.1% | +$37.6K |
|
318
Guardant Health
GH
$6.77B
| $60.5M | 0.02% |
1,690,281
+690,281
| +69% | +$24.7M |
|
319
Newmont
NEM
$86B
| $59.7M | 0.02% |
1,400,000
+150,000
| +12% | +$6.4M |
|
320
Extreme Networks
EXTR
$2.94B
| $53.8M | 0.01% |
2,065,980
-1,955,795
| -49% | -$50.9M |
|
321
Encompass Health
EHC
$12.5B
| $53.3M | 0.01% |
787,849
| – | – |
|
322
Bentley Systems
BSY
$15.9B
| $53.1M | 0.01% |
979,001
-234,742
| -19% | -$12.7M |
|
|
BRSL
323
Brightstar Lottery PLC
BRSL
$3.18B
| $52.5M | 0.01% |
1,647,850
-1,082,000
| -40% | -$34.5M |
|
324
CAVA Group
CAVA
$7.33B
| $51.2M | 0.01% |
+1,250,000
| New | +$51.2M |
|
325
Sempra
SRE
$54.5B
| $50.2M | 0.01% |
689,460
+26
| +0% | +$1.89K |
|